Reuters logo
BRIEF-Oxford biomedica says Trovax shown to induce beneficial anti-tumour immune responses
February 24, 2017 / 7:30 AM / 8 months ago

BRIEF-Oxford biomedica says Trovax shown to induce beneficial anti-tumour immune responses

Feb 24 (Reuters) - Oxford Biomedica Plc

* Cyclophosphamide and Trovax independently shown to induce highly beneficial anti-tumour immune responses

* Both drugs resulting in significantly prolonged survival of advanced colorectal cancer patients Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below